Kulturplatte nach Genome Editing mit BEC high res
Kulturplatte nach Genome Editing mit BEC high res

Developing Powerful Production Strains

Home/ Sectors/ Life Science/ Strain Development
It all starts with the strain
In fermentation, the production strain means everything. Whether you're looking to identify a suitable microbial strain for your application or to optimise a microbe already in use, our expertise and know-how in discovering and optimising microbial strains can develop a solution fit for your project.

Fermentation as a scalable technology starts with the microorganisms that act as factories in which cells are capable of producing very precise ingredients through very rapid duplication. Fermenting enzymes requires the synergy between protein of interest and microorganisms. Different enzyme classes, and even different classes of enzymes from the same class, are known to be better suited to specific microorganisms. To achieve optimum production yield of the enzyme, genetic engineering or evolutionary optimisation methods can be explored to best reach target strain productivity.

Strain development webpage 01

For the production of enzymes and proteins, we access prokaryotic host organisms (including Escherichia coli, Bacillus subtilis, Pseudomonas stutzeri, Streptomyces lividans and Corynebacterium glutamicum) and eukaryotic host organisms (including Pichia pastoris, Kluyveromyces lactis and Aspergillus niger). For the expression of a gene of interest, the gene can be inserted into an expression host via BRAIN’s metagenomic Cas nuclease BMC (proprietary CRISPR-Cas) or classical methods utilising different auxotrophic and antibiotic selection markers.

Our USPs in microbial strain development:

  • Own Bioarchive with thousands of microorganisms
  • Application-specific microbial toolboxes of value-added strains with defined properties
  • Long-standing experience in strain development working on many types of producer strains
  • Broad application knowledge in different industries
  • Comprehensive technology package of microbiology, molecular biology, bioinformatics, assay development, analytics, and bioprocess development
B Xtra
P Xtra
Aniger
E Xtra
BRAIN Biotech Group
20 May 2025
BRAIN Biotech announces buy-out of minorities, new continental European production site, and expansion of its Baking Application Centre
BRAIN Biotech has acquired full ownership of its Dutch subsidiary Breatec B.V. and leased a new, larger site near Den Bosch to support its expanding bakery enzymes business.
Read more
Adobe Stock 283773852 Converted
16 May 2025
From AI to Application: Turning Enzyme Discovery into Scalable Reality
AI is revolutionising enzyme discovery - but turning predictions into real-world products is where the challenge begins. We explore the missing link between enzyme design and scalable, industrial application.
Read more
Adobe Stock 297148229
15 May 2025
Navigating the Future of Dairy: Innovation, Adaptation and the Enzyme Advantage
From clean labels to lactose-free innovation, and from sustainability goals to hybrid dairy products dairy processors face both challenge and opportunity. We review the trends reshaping dairy and the strategic role enzymes play in driving innovation and efficiency.
Read more
Synthetic biology
9 May 2025
SynBioBeta 2025: Key Industry Trends and Challenges in Synthetic Biology
Synthetic biology is no longer the future - it's reshaping industries today. At SynBioBeta 2025, global innovators came together to explore how AI is accelerating biological discovery and transforming fields from healthcare to biomanufacturing.
Read more
Adobe Stock 307369527
25 Apr 2025
A Natural Answer to Colour Extraction Challenges
As the U.S. Food and Drug Administration (FDA) announces its phased withdrawal of petroleum-based synthetic dyes from the national food supply, the global spotlight is shifting towards more sustainable, health-conscious alternatives.
Read more
20250129 101512
28 Feb 2025
Strengthening Our Presence in North America
Aligning our Food, Baking and Beverages enzyme business under the leadership of Ludwig Klermund, and streamlining our US operations is a significant step forward in our North American growth strategy.
Read more
1740553738918
26 Feb 2025
BRAIN Biotech Group announce 3M FY 24/25
BRAIN Biotech AG publishes its financial figures for the first three months of the fiscal year, reporting for the first time on its new two-pillar structure, with strong double digit sales growth in the core BRAINBiocatalysts division
Read more
Adobe Stock 195217272
13 Feb 2025
Biocatalysts Food, Baking & Beverage Further Optimising Customer Experience and Operating Efficiency
To reinforce Biocatalysts market presence and further optimise customer experience, the company is streamlining its enzyme business for Food, Baking and Beverages as a new business unit Biocatalysts Food, led by Pieter-Jan Heijkoop
Read more
BBLS Option 1 01
2 Feb 2025
Accelerating Our Growth in Life Sciences and Fermentation Services
As part of the corporate growth strategy, BRAINBiocatalysts is pleased to announce that Daren Bryce will lead the Life Sciences and Fermentation Business Unit.
Read more
BRAIN AR2324
15 Jan 2025
Annual Report 2023/24: BRAIN Biotech AG acts from a strong cash position and is confident about its growth prospects
BRAIN Biotech AG, a leading provider of integrated solutions for the biologisation of industry, today published its Annual Report 2023/24.
Read more
Adobe Stock 195217272
2 Jan 2025
Ingredient Innovation Leading the Food Industry in 2025
As we enter the new year, we take a look at the stand out market trends driving innovation in the food industry and shaping the future of food ingredient development over the coming year
Read more
BRAIN Biotech Group
12 Dec 2024
BRAIN Biotech AG sharpens focus on profitable growth
At it's fifth Capital Markets Day, BRAIN Biotech AG announce the creation of a new growth segment for sharpening focus on profitable growth in its enzyme business, and communicate the completion of significant royalties transactions improving liquidity and earnings.
Read more
Sign up to our newsletter
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.